+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Addiction Disorders Drugs Market by Product Type (Branded, Generic), Dosage Form (Capsule, Film, Injectable Solution), Administration Route, Drug Class, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Addiction Disorders Drugs Market by Product Type (Branded, Generic), Dosage Form (Capsule, Film, Injectable Solution), Administration Route, Drug Class, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Addiction Disorders Drugs Market by Product Type (Branded, Generic), Dosage Form (Capsule, Film, Injectable Solution), Administration Route, Drug Class, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337785
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The addiction disorders drug market is undergoing significant transformation, driven by converging forces in science, technology, and policy. For senior decision-makers, understanding the evolving landscape—including innovation, regulation, and market dynamics—is essential for optimizing investment and strategic direction in this complex therapeutic field.

Market Snapshot: Growth Trends in the Addiction Disorders Drug Market

The Addiction Disorders Drugs Market grew from USD 27.08 billion in 2024 to USD 28.89 billion in 2025. It is expected to continue growing at a CAGR of 6.48%, reaching USD 39.49 billion by 2030. This growth reflects both rising global demand and the increasing burden of addiction disorders on health systems and payers. The market spans branded and generic drugs addressing dependencies such as alcohol, nicotine, and opioids, amid changing regulatory landscapes and competition from both established and new entrants.

Scope & Segmentation

This report provides a structured analysis of the addiction disorders drug market, segmented to capture the drivers of growth and competitive dynamics:

  • Product Types: Branded, Generic
  • Dosage Forms: Capsule, Film, Injectable Solution, Patch, Tablet
  • Administration Routes: Injectable, Oral, Sublingual, Transdermal
  • Drug Classes: Alcohol (Acamprosate, Disulfiram, Naltrexone), Nicotine (Bupropion, Nicotine Replacement Therapy—Gum, Inhaler, Lozenge, Patch—Varenicline), Opioid (Buprenorphine, Methadone, Naltrexone)
  • Distribution Channels: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • End Users: Clinics, Homecare Settings, Hospitals
  • Key Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (including United Kingdom, Germany, France, Russia, UAE, Saudi Arabia, South Africa, and others), Asia Pacific (including China, India, Japan, Australia, South Korea, and more)
  • Major Companies: Pfizer Inc., Johnson & Johnson, Indivior plc, Alkermes plc, Camurus AB, Orexo AB, BioDelivery Sciences International, Titan Pharmaceuticals, Mallinckrodt, Teva Pharmaceutical Industries

Key Takeaways for Decision-Makers

  • Scientific advancements in neuroscience and pharmacotherapy are reshaping treatment approaches, increasing both efficacy and competition.
  • The market landscape is complex, with diverse product pipelines and a shift toward patient-centric therapies supported by digital health tools and adherence platforms.
  • Collaboration is increasing across biopharma, generics, digital health, and research organizations, driving speed to market and expanding access.
  • Stakeholders face ongoing regulatory adaptation, including evolving approval pathways and value-based reimbursement models that link payment to patient outcomes.
  • Expanding adoption of advanced dosage forms and administration routes offers opportunities for differentiation, but requires tailored commercialization strategies.
  • Generic drugs are strengthening market competition, particularly in formulary access and regional expansion, driving a need for clear value differentiation among branded therapies.

Tariff Impact on Supply Chain and Pricing

Recent tariff changes in the United States have increased costs for key pharmaceutical ingredients, prompting companies to reevaluate supply chains. Many are considering domestic manufacturing or diversification to regional partners, resulting in both increased operational expenses and delayed scaling. These developments are affecting pricing strategies, with businesses adopting scenario planning to address market disruption and maintain product access for patients.

Methodology & Data Sources

Analysis is grounded in a blend of primary and secondary research, including direct interviews with clinicians, payers, and supply chain experts. Data integrity is assured through triangulation across peer-reviewed literature, market reports, regulatory filings, and proprietary databases, with expert validation sessions refining key assumptions.

Why This Report Matters

  • Enables senior leaders to anticipate disruptive trends, regulatory shifts, and emerging growth opportunities in the addiction disorders drug sector.
  • Delivers actionable segmentation, regional, and supply chain insights to support effective commercial and investment decisions.
  • Provides a comprehensive understanding of competitive strategies and technology adoption to inform robust operational planning.

Conclusion

Companies that actively adapt to evolving science, regulation, and patient needs will position themselves for sustained success. Strategic insight from this report supports both immediate and long-range decision-making in a dynamic global market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of extended-release buprenorphine implants for opioid use disorder improving adherence and outcomes
5.2. Rapid integration of mobile digital therapeutic platforms with pharmacotherapy for alcohol use disorder monitoring and support
5.3. Increasing development of long-acting injectable naltrexone formulations to enhance patient retention in relapse prevention
5.4. Emerging role of pharmacogenomics in guiding personalized medication dosing for co-occurring addiction and psychiatric conditions
5.5. Growing investment in combination therapies pairing anti-craving medications with cognitive behavioral digital tools to reduce relapse
5.6. Shift toward non-opioid neuropeptide modulators targeting stress-induced relapse pathways in substance use disorders research
5.7. Expansion of telehealth prescribing regulations accelerating access to medication-assisted treatment for remote and underserved populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Addiction Disorders Drugs Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Addiction Disorders Drugs Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Film
9.4. Injectable Solution
9.5. Patch
9.6. Tablet
10. Addiction Disorders Drugs Market, by Administration Route
10.1. Introduction
10.2. Injectable
10.3. Oral
10.4. Sublingual
10.5. Transdermal
11. Addiction Disorders Drugs Market, by Drug Class
11.1. Introduction
11.2. Alcohol
11.2.1. Acamprosate
11.2.1.1. Branded
11.2.1.2. Generic
11.2.2. Disulfiram
11.2.2.1. Branded
11.2.2.2. Generic
11.2.3. Naltrexone
11.2.3.1. Branded
11.2.3.2. Generic
11.3. Nicotine
11.3.1. Bupropion
11.3.1.1. Branded
11.3.1.2. Generic
11.3.2. Nicotine Replacement Therapy
11.3.2.1. Gum
11.3.2.2. Inhaler
11.3.2.3. Lozenge
11.3.2.4. Patch
11.3.3. Varenicline
11.3.3.1. Branded
11.3.3.2. Generic
11.4. Opioid
11.4.1. Buprenorphine
11.4.1.1. Branded
11.4.1.2. Generic
11.4.2. Methadone
11.4.2.1. Branded
11.4.2.2. Generic
11.4.3. Naltrexone
11.4.3.1. Branded
11.4.3.2. Generic
12. Addiction Disorders Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Addiction Disorders Drugs Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Homecare Settings
13.4. Hospitals
14. Americas Addiction Disorders Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Addiction Disorders Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Addiction Disorders Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Johnson & Johnson
17.3.3. Indivior plc
17.3.4. Alkermes plc
17.3.5. Camurus AB
17.3.6. Orexo AB
17.3.7. BioDelivery Sciences International, Inc.
17.3.8. Titan Pharmaceuticals, Inc.
17.3.9. Mallinckrodt plc
17.3.10. Teva Pharmaceutical Industries Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ADDICTION DISORDERS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ADDICTION DISORDERS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ADDICTION DISORDERS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ADDICTION DISORDERS DRUGS MARKET: RESEARCHAI
FIGURE 28. ADDICTION DISORDERS DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 29. ADDICTION DISORDERS DRUGS MARKET: RESEARCHCONTACTS
FIGURE 30. ADDICTION DISORDERS DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ADDICTION DISORDERS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY FILM, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY FILM, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY LOZENGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY LOZENGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 219. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 222. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 223. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 224. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 225. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 226. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 227. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2024 (USD MILLION)
TABLE 228. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2025-2030 (USD MILLION)
TABLE 229. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 230. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 231. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 232. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 233. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 234. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 235. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2024 (USD MILLION)
TABLE 236. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2025-2030 (USD MILLION)
TABLE 237. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2018-2024 (USD MILLION)
TABLE 238. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2025-2030 (USD MILLION)
TABLE 239. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 240. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 241. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2018-2024 (USD MILLION)
TABLE 242. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2025-2030 (USD MILLION)
TABLE 243. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2024 (USD MILLION)
TABLE 244. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2025-2030 (USD MILLION)
TABLE 245. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2018-2024 (USD MILLION)
TABLE 246. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2025-2030 (USD MILLION)
TABLE 247. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2018-2024 (USD MILLION)
TABLE 248. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2025-2030 (USD MILLION)
TABLE 249. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 250. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 251. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 258. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 259. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 260. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 261. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 263. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2024 (USD MILLION)
TABLE 264. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2025-2030 (USD MILLION)
TABLE 265. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 266. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 267. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 268. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 269. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 270. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 271. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2024 (USD MILLION)
TABLE 272. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2025-2030 (USD MILLION)
TABLE 273. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2018-2024 (USD MILLION)
TABLE 274. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2025-2030 (USD MILLION)
TABLE 275. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 276. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 277. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2018-2024 (USD MILLION)
TABLE 278. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2025-2030 (USD MILLION)
TABLE 279. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2024 (USD MILLION)
TABLE 280. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2025-2030 (USD MILLION)
TABLE 281. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2018-2024 (USD MILLION)
TABLE 282. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2025-2030 (USD MILLION)
TABLE 283. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2018-2024 (USD MILLION)
TABLE 284. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2025-2030 (USD MILLION)
TABLE 285. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 286. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 287. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc.
  • Johnson & Johnson
  • Indivior plc
  • Alkermes plc
  • Camurus AB
  • Orexo AB
  • BioDelivery Sciences International, Inc.
  • Titan Pharmaceuticals, Inc.
  • Mallinckrodt plc
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 28.89 Billion
Forecasted Market Value ( USD ) by 2030 $ 39.49 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Addiction Therapeutics - Global Strategic Business Report - Product Image

Addiction Therapeutics - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Smoking Cessation & Nicotine De-Addiction Product Market by Product Type, Route Of Administration, Distribution Channel, End User, Nicotine Strength - Global Forecast 2025-2030 - Product Image

Smoking Cessation & Nicotine De-Addiction Product Market by Product Type, Route Of Administration, Distribution Channel, End User, Nicotine Strength - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Substance Abuse and Addiction Treatment Market Report 2025 - Product Image

Substance Abuse and Addiction Treatment Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Addictions Therapeutics Market Report 2025 - Product Image

Addictions Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Addiction Treatment - Global Strategic Business Report - Product Image

Addiction Treatment - Global Strategic Business Report

  • Report
  • 242 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.